It’s been almost a year since the COVID-19 Pandemic had started . Many medical agencies are doing their best to create a vaccine for this virus . Since it is a RNA virus it changes it’s form very frequently . This makes it tough for the medical teams to make a vaccine . The entire world is fighting to put and end to this pandemic . Vaccines are our only hope in this case .
The medical brand Pfizer had said that they had received the permission for the emergency use of their COVID-19 vaccine in the UK . According to them this permission was given to them on Wednesday . Apart from Pfizer BioNTech has received the permission .
With this move Britain becomes one of the first countries to begin vaccinating it’s population . This will truly be an effective measure to minimize the effect of the virus .
The U.S. and the European Union are also not far behind in this regard . Moderna Inc. is also making a vaccine which is similar to that made by Pfizer .
Pfizer said that it would immediately start to ship limited supplies of the vaccine to the UK . If the U.S. Food And Drug Administration too gives them the green signal then they will begin to supply the virus on a much larger scale . This decision is expected to come within the next week .
Pfizer CEO Albert Bourla calls this a “historic moment “
The CEO of Pfizer Albert Bourla declared this decision to be “ a historic moment “ . The UK has truly set an example for the rest of the world .
In an interview Bourla said , “We are focusing on moving with the same level of urgency to safely supply a high-quality vaccine around the world,” . This proves the fact that he is equally concerned about the safety of the world as a whole . The vaccine needs to be procured by every Nation if it wants to curb the growth of this Pandemic .
The UK has ordered enough vaccine for 20 million people . It’s not clear though that how much of the stock will arrive by the end of this year . The most significant challenge that will be faced is that the Pfizer vaccine needs to stored at very cold temperatures . If this is not maintained then the vaccine cannot be stored . Apart from the distribution challenges this is also a major issue that needs to be kept in mind .
For protection two doses are required three weeks apart . The health care workers , nursing home residents and the elderly people will get the vaccine first .
The vaccine which has been made by U.S. based Pfizer and German based BioNTech was tested in tens of thousands . The early results suggest that the is 95% effective at preventing mild to severe COVID-19 infections . The companies also said that the vaccine had no major side-effects . In some cases though people may face temporary pain and flu-like reactions immediately after the vaccine is given .
The Pfizer vaccine has also been tested on a small number of children who are not above the age of 12 . Reports of tests on pregnant mothers have not yet been received .